Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-04 Sale | 2024-01-08 4:43 pm | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $45.29 | $1,811,600 | 53,622 (Direct) | View |
| 2023-06-08 Sale | 2023-06-12 4:13 pm | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $46.61 | $1,864,239 | 207,244 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-15 8:40 pm | N/A 2034-02-12 | Keros Therapeutics Inc. | KROS | Regnante Keith CHIEF FINANCIAL OFFICER | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-11-04 Exercise | 2024-01-08 4:43 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $16 | 53,622 (Direct) | View |
| 2024-01-04 Exercise | 2024-01-08 4:43 pm | N/A 2030-04-06 | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $0 | 53,622 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 4:13 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $16 | 207,244 (Direct) | View |
| 2023-06-08 Exercise | 2023-06-12 4:13 pm | N/A 2030-04-06 | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $0 | 207,244 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-17 4:14 pm | N/A 2033-02-15 | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:15 pm | N/A 2032-01-20 | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-01-10 Option Award | 2021-01-12 5:25 pm | N/A 2031-01-09 | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 49,150 | $0 | 49,150 (Direct) | View |
| 2020-04-07 Option Award | 2020-04-08 9:02 pm | N/A 2030-04-06 | Keros Therapeutics Inc. | KROS | Regnante Keith Chief Financial Officer | 152,052 | $0 | 152,052 (Direct) | View |